NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs021180004

Registered date:13/03/2019

Effectiveness of BBG

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedCataract, Vitreoretinal diseases
Date of first enrollment11/11/2013
Target sample size220
Countries of recruitment
Study typeInterventional
Intervention(s)Intracameral or intravitreal injection of Brilliant blue G

Outcome(s)

Primary OutcomeVisual acuity
Secondary OutcomeRetinal morphological changes measured byoOptical coherence tomography (OCT)

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderBoth
Include criteriaNeeds of use of Brilliant blue G in cataract or vitreous surgery
Exclude criteriaWithout severe ocular infections

Related Information

Contact

Public contact
Name Sanae Abe
Address Hondo 1-1-1, Akita 010-8543, Japan Akita Japan 010-8543
Telephone +81-18-884-6167
E-mail sanaeabe@med.akita-u.ac.jp
Affiliation Akita University Hospital
Scientific contact
Name Samae Abe
Address Hondo 1-1-1, Akita 010-8543, Japan Akita Japan 010-8543
Telephone +81-18-884-6167
E-mail sanaeabe@med.akita-u.ac.jp
Affiliation Akita University Hospital